Colorectal cancer: CRC—all about microbial products and barrier function?

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nature Reviews Gastroenterology &Hepatology

• Publication date

  2012-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrgastro.2012.220PMID 23165234PMCID PMC3612125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures.

  2013cited by this paper
• Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.

  2012cited by this paper
• Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides

  2012cited by this paper
• Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

  2012cited by this paper
• Mucosal healing in inflammatory bowel diseases: a systematic review

  2012cited by this paper
• Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans

  2012cited by this paper
• Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

  2012cited by this paper
• New endoscopic approaches in IBD.

  2011cited by this paper
• Results from the 2 nd Scientific Workshop of the ECCO ( I ) : Impact of mucosal healing on the course of inflammatory bowel disease

  2011cited by this paper
• Measurement of disease activity in ulcerative colitis: Interobserver agreement and predictors of severity

  2011cited by this paper
• Results of the 2 nd part Scientific Workshop of the ECCO ( II ) : Measures and markers of prediction to achieve , detect , and monitor intestinal healing in Inflammatory Bowel Disease

  2011cited by this paper
• Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention

  2011cited by this paper
• Translational Gastroenterology

  2011cited by this paper
• Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis

  2010cited by this paper
• Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas

  2010cited by this paper
• The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis.

  2008cited by this paper
• Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.

  2007cited by this paper
• A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.

  2007cited by this paper
• Guidelines for the management of inflammatory bowel disease in adults

  2004cited by this paper

• The rise and evolving role of Fusobacterium nucleatum subspecies

  2025cites this paper
• The intestinal barrier: a pivotal role in health, inflammation, and cancer.

  2025cites this paper
• Therapeutic Potential of ZnO-Nanoparticles Synthesized Using Portulaca oleracea in Cancer Treatment: A Comprehensive Narrative Review

  2024cites this paper
• Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug.

  2024cites this paper
• IL-1β and the Intestinal Epithelial Tight Junction Barrier

  2021cites this paper
• Colorectal Cancer Patients Have Four Specific Bacterial Species in Oral and Gut Microbiota in Common—A Metagenomic Comparison with Healthy Subjects

  2021cites this paper
• GPR120 prevents colorectal adenocarcinoma progression by sustaining the mucosal barrier integrity

  2021cites this paper
• Role of lung and gut microbiota on lung cancer pathogenesis

  2021cites this paper
• Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer

  2021cites this paper
• The Association of Diet-Modulated Gut Microbiota on Development and Treatment of Colorectal Cancer

  2021cites this paper
• Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression in an Immune Microenvironment

  2020cites this paper
• Dietary legumes, intestinal microbiota, inflammation and colorectal cancer

  2020cites this paper
• OTT_A_253598 8691..8704

  2020cites this paper
• Involvement of Oral Microbiota in the Gut Microbiota of Colorectal Cancer

  2020cites this paper
• Effects of Huaier Extract on Ameliorating Colitis-Associated Colorectal Tumorigenesis in Mice

  2020cites this paper
• Host DNA contents in fecal metagenomics as a biomarker for intestinal diseases and effective treatment

  2020cites this paper
• The role of mouse models in colorectal cancer research—The need and the importance of the orthotopic models

  2020cites this paper
• Dysbiosis of the Gut Microbiome in Lung Cancer

  2019cites this paper
• In vitro and in vivo resistance of Lactobacillus rhamnosus GG carried by a mixed pineapple (Ananas comosus L. Merril) and jussara (Euterpe edulis Martius) juice to the gastrointestinal tract.

  2019cites this paper
• Compromised intestinal barrier underlies gut microbiota dysbiosis of intestinal diseases

  2019cites this paper
• Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer

  2018cites this paper
• The microbiome, its molecular mechanisms and its potential as a therapeutic strategy against colorectal carcinogenesis (Review)

  2018cites this paper
• Next-generation sequencing: recent applications to the analysis of colorectal cancer

  2017cites this paper
• Microbial Communities Associated with Primary and Metastatic Head and Neck Squamous Cell Carcinoma – A High Fusobacterial and Low Streptococcal Signature

  2017cites this paper
• Microbes and Cancer.

  2017cites this paper
• The state of immune system during the use of probiotic lactobacilli in complex treatment of papillomavirus infection

  2017cites this paper
• Prebiotics and Probiotics in Altering Microbiota: Implications in Colorectal Cancer

  2017cites this paper
• Microbiota: a key orchestrator of cancer therapy

  2017cites this paper
• Polymorphisms in the CHIT1 gene: Associations with colorectal cancer

  2016cites this paper
• Evolutionary biologic changes of gut microbiota in an ‘adenoma-carcinoma sequence’ mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine

  2016cites this paper
• Probiotics, prebiotics and colorectal cancer prevention.

  2016cites this paper
• Best Practice & Research Clinical Gastroenterology

  2016cites this paper
• The role of the microbiota in inflammation, carcinogenesis, and cancer therapy

  2015cites this paper
• Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways.

  2015cites this paper
• The multifaceted role of the intestinal microbiota in colon cancer.

  2014cites this paper
• The therapeutic value of targeting inflammation in gastrointestinal cancers.

  2014cites this paper
• Host immune response to infection and cancer: unexpected commonalities.

  2014cites this paper
• Microbes, microbiota, and colon cancer.

  2014cites this paper
• Dual function of MyD88 in inflammation and oncogenesis: implications for therapeutic intervention

  2014cites this paper
• Chronic ulcerative colitis and colorectal cancer.

  2014cites this paper
• Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

  2013cites this paper
• The Microbiome and Colorectal Neoplasia: Environmental Modifiers of Dysbiosis

  2013cites this paper
• MyD88 and its divergent toll in carcinogenesis.

  2013cites this paper
• Deep Sequencing and Functional Analyses Identify a Role of Fusobacterium Species in Colorectal Tumorigenesis

  2013cites this paper